Advertisement
Screener

Grace Therapeutics, Inc. (GRCE) Shortterm Deposits Classified As Cash Equivalents

Grace Therapeutics, Inc. Shortterm Deposits Classified As Cash Equivalents

Grace Therapeutics, Inc. (GRCE) had Shortterm Deposits Classified As Cash Equivalents of CAD 4.19 million as of 2018-03-31, per its 20-F filed 2018-06-29.

Discontinued › Notes

ifrs-full:ShorttermDepositsClassifiedAsCashEquivalents · last filed 2018-06-29

  • 2018-03-31: Shortterm Deposits Classified As Cash Equivalents 4.19M CAD.
  • 2017-03-31: Shortterm Deposits Classified As Cash Equivalents 2.99M CAD.
  • 2017-02-28: Shortterm Deposits Classified As Cash Equivalents 2.99M CAD.

CAD

Period endShortterm Deposits Classified As Cash Equivalents
2018-03-314.19M CAD
20-F · filed 2018-06-29
2017-03-312.99M CAD
20-F · filed 2018-06-29
2017-02-282.99M CAD
20-F · filed 2018-06-29

USD

Period endShortterm Deposits Classified As Cash Equivalents
2018-03-31$3.25M
20-F · filed 2018-06-29
2017-03-31$2.25M
20-F · filed 2018-06-29
2017-02-28$2.25M
20-F · filed 2018-06-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
PDS Biotechnology Corp (PDSB)United States$0.045B
SCYNEXIS INC (SCYX)United States$0.045B
Werewolf Therapeutics, Inc. (HOWL)United States$0.047B
VERU INC. (VERU)United States$0.043B-3.93
Dogwood Therapeutics, Inc. (DWTX)United States$0.049B
Lite Strategy, Inc. (LITS)United States$0.049B
Elicio Therapeutics, Inc. (ELTX)United States$0.049B
Kairos Pharma, LTD. (KAPA)United States$0.041B
Incannex Healthcare Inc. (IXHL)$0.040B-22.32
Karyopharm Therapeutics Inc. (KPTI)United States$0.039B-0.98